阿糖胞苷

方法共72例用HAD（高三尖杉酯碱、阿糖胞苷及柔红霉素）方案进行诱导缓解治疗的原发初治AML患者进入本研究。

Methods 72 cases of new diagnosed de novo AML treated with HAD ( homoharringtonine , cytosine arabinoside and daunorubicin ) regimen were enrolled .

【目的】探讨细胞色素C（CYTC）对小剂量阿糖胞苷（LD-Ara-c）诱导白血病细胞凋亡的影响。

【 Objective 】 To discuss the role of cytochrome C ( Cyt C ) in leukemia cell apoptosis induced by low-dose cytosine arabinoside ( LD-Ara-c ) .

细胞色素C对阿糖胞苷诱导白血病细胞凋亡的影响

The Role of Cytochrome C in Leukemia Cell Apoptosis Induced by LD-cytosine Arabinoside

通过对Ara-C在不同剂量和疗程时抗白血病的机理研究，验证大剂量阿糖胞苷（HD-Arac）治疗血液肿瘤的优越性。

In addition to study the antileukemic mechanism of Ara-C.

阿糖胞苷诱导HL-60细胞凋亡的研究

Ara c induced apoptosis in human myeloid leukemia cell line HL 60

α干扰素联合阿糖胞苷对白血病K562细胞的诱导凋亡作用及其机制

Apoptotic Effects and Its Mechanisms on Leukemic K562 Cells Caused by Interferon-alpha Combined with Cytarabine

尼莫地平加强阿糖胞苷诱导HL-60细胞凋亡的机制研究

Study on the Enhancing Mechanisms of Nimodipine in HL-60 Apoptosis Induced by Cytarabine

RP-HPLC法测定细胞内三磷酸阿糖胞苷浓度

Determination of Intracellular Ara-CTP Level by RP-HPLC

香菇多糖协同阿糖胞苷对HL-60白血病细胞增殖力的影响

The Effects of Lentinan Polysaccharide and Ara-c on the Ability of HL-60 Cells Proliferation

我们此前报道了氯法拉滨与阿糖胞苷联合使用治疗AML的可行性。

We previously reported the feasibility of clofarabine and cytarabine combinations in AML .

抗HSV1单克隆抗体阿糖胞苷偶联物制备条件的分步优化

Fractional optimization experiment of production condition for anti-HSV_1 monoclonal antibody conjugate and its determination

氟达拉滨联合阿糖胞苷对HL-60细胞存活率及代谢酶的影响

Effect of fludarabine combined with cytarabine on the viability and metabolic enzymes of HL-60 cells

RNA能增强高三尖杉酯碱联合小剂量阿糖胞苷对K562细胞增殖的抑制作用。

RNA could intensify the inhibitory effect of homoharringtonine and low-dose of arabinsyl cytosine on the cell proliferation of K562 cells .

抗分化HL－60／RA和分化敏感HL－60细胞对阿糖胞苷、三尖杉酯碱等抗肿瘤药物细胞毒作用的敏感性比较

Comparison of the Sensitivity of Retinoic Acid Sensitivity of Resistant HL-60 Cell Lines to Several Anti-leukemia Drugs

小剂量阿糖胞苷（Arac）或三尖杉脂碱（H）化疗18例，CR率22.2%（418）。

Low dose Ara C or harringtonine were given in 16 elderly patients and the CR rate was 22.2 % ( 4 / 18 ) .

以bcl-2为靶标siRNA-2提高HL-60细胞对阿糖胞苷的敏感性

SiRNA-2 targeting bcl-2 can enhance the drug-sensitivity of HL-60 cells to cytosine arabinoside

培养第三天加入终浓度为5mg／ml的阿糖胞苷以抑制神经胶质细胞的过度增殖。

At the 3rd day , in order to suppress the proliferation of glial cells , cytarabine was added .

目的：进一步了解MAC（马法兰、阿糖胞苷和环磷酰胺）预处理方案对白血病患者骨髓移植后内分泌功能的影响。

Objective : To investigate the effect of MAC conditioning regimen on endocrine glands function in leukemia patients after bone marrow transplantation ( BMT ) .

不同剂量阿糖胞苷的DA方案治疗CD7抗原阳性急性髓系白血病疗效分析

Chemotherapeutic effect of two different doses of cytarabine combined with anthracycline for CD7 positive acute myeloid leukemia

Bcl-2/Bax比值下降可能是阿糖胞苷诱导HL-60细胞凋亡的主要机制之一。

Decrease of expression ratio of Bcl-2 / Bax proteins may be one of the main mechanisms in HL-60 apoptosis induced by Ara-C.

预处理方案为全身照射+环磷酰胺（TBI+CTX）或马法兰、阿糖胞苷、CTX和环己亚硝脲（MAC+CCNU）。

Conditioning regimens were TBI + Cy ( total body irradiation + cyclophosphamide ) or MAC + CCNU .

阿糖胞苷、阿克拉霉素联合G-CSF治疗50例复发急性髓系白血病的临床研究

Low-dose Cytarabine and Aclarubicin in Combination with Granulocyte Colony-Stimulating Factor Priming in 50 Patients with Relapsed Acute Myeloid Leukemia

大剂量阿糖胞苷在急非淋白血病患儿体内的药物动力学MAG方案对恶性血液病患者造血干细胞动员作用的研究

Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies

阿糖胞苷增强白血病细胞B7分子表达及促进双功能抗体对靶细胞的杀伤

Cytarabine enhances B7 expression on leukemic cells and promotes cytotoxic effect of bispecific antibody against target cells

小剂量高三尖杉酯碱、阿糖胞苷联合G-CSF治疗急性髓细胞白血病28例临床分析

Low dose of homoharringtonine and cytarabine combined with G-CSF for treatment of acute myelocytic leukemia : report of 28 cases

诱导治疗主要采用全反式维A酸诱导分化，继以柔红霉素-阿糖胞苷（DA）、三尖杉酯碱-阿糖胞苷（HA）、柏林-法兰克福-慕尼黑（BFM）方案巩固治疗。

The patients were treated with protocol including induction of differentiation with ATRA followed by consolidation therapy with DA , HA or BFM protocol .

目的探讨小剂量化疗药物〔高三尖杉酯碱（HHar）、阿克拉霉素（ACR）、阿糖胞苷（Ara-c）〕治疗急性白血病（AL）的可能机制。

Objective To explore the possible mechanism of low - dose chemotherapeutic drugs in treating acute leukemia .

56例接受大剂量阿糖胞苷（HDAraC）强化治疗，其5年EFS率为（47.2±12.9）%。

The 5 year EFS rate of 56 patients received high-dose cytarabine ( HD-Ara-C ) as intensification therapy was ( 47.2 ± 12.9 ) % .

目的：研究香菇多糖协同阿糖胞苷（Ara-c）对HL-60白血病细胞增殖力的影响。

Objective : To study the effects of lentinan polysaccharide and Ara-c in the ability of proliferation on HL-60 cells .

目的：建立测定阿糖胞苷（Ara－C）及其代谢产物阿糖尿苷（Ara－U）血药浓度的方法，并用于5例急性髓细胞白血病（AML）患者血药浓度监测。

OBJECTIVE : To develop a method for the determination of Cytarabine ( AraC ) and its metabolite ( uracil arabinoside , Ara-U ) in plasma of AML patients .